XTX Topco Ltd Buys 12,820 Shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

XTX Topco Ltd lifted its stake in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 273.7% in the 2nd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 17,504 shares of the company’s stock after buying an additional 12,820 shares during the period. XTX Topco Ltd’s holdings in Acadia Healthcare were worth $1,182,000 as of its most recent SEC filing.

A number of other large investors also recently modified their holdings of ACHC. Blue Trust Inc. raised its position in Acadia Healthcare by 86.1% in the second quarter. Blue Trust Inc. now owns 536 shares of the company’s stock valued at $36,000 after purchasing an additional 248 shares during the last quarter. Mather Group LLC. acquired a new position in shares of Acadia Healthcare in the first quarter valued at approximately $48,000. nVerses Capital LLC bought a new position in Acadia Healthcare in the 2nd quarter valued at approximately $95,000. Innealta Capital LLC acquired a new stake in Acadia Healthcare during the 2nd quarter worth approximately $164,000. Finally, Capstone Investment Advisors LLC bought a new stake in Acadia Healthcare during the 4th quarter worth approximately $204,000.

Acadia Healthcare Price Performance

Acadia Healthcare stock opened at $76.40 on Friday. The stock has a market capitalization of $7.09 billion, a price-to-earnings ratio of -545.71, a PEG ratio of 2.22 and a beta of 1.30. Acadia Healthcare Company, Inc. has a 52-week low of $62.04 and a 52-week high of $87.77. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.18 and a current ratio of 1.18. The stock’s 50 day moving average price is $73.34 and its two-hundred day moving average price is $72.12.

Acadia Healthcare (NASDAQ:ACHC) last posted its quarterly earnings results on Wednesday, July 31st. The company reported $0.91 EPS for the quarter, topping analysts’ consensus estimates of $0.87 by $0.04. Acadia Healthcare had a negative net margin of 0.17% and a positive return on equity of 11.42%. The business had revenue of $796.00 million during the quarter, compared to analysts’ expectations of $784.38 million. During the same period last year, the company posted $0.92 earnings per share. The business’s quarterly revenue was up 8.8% on a year-over-year basis. On average, equities analysts predict that Acadia Healthcare Company, Inc. will post 3.51 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently commented on ACHC shares. Deutsche Bank Aktiengesellschaft lifted their price target on shares of Acadia Healthcare from $70.00 to $75.00 and gave the stock a “hold” rating in a report on Friday, August 2nd. Cantor Fitzgerald reaffirmed a “neutral” rating and set a $90.00 target price on shares of Acadia Healthcare in a report on Monday, August 19th. Barclays decreased their price target on Acadia Healthcare from $89.00 to $83.00 and set an “overweight” rating for the company in a research note on Thursday, August 1st. Finally, Royal Bank of Canada reaffirmed an “outperform” rating and issued a $94.00 price objective on shares of Acadia Healthcare in a research note on Friday. One investment analyst has rated the stock with a sell rating, three have given a hold rating and six have given a buy rating to the stock. According to data from MarketBeat, Acadia Healthcare has a consensus rating of “Moderate Buy” and an average price target of $87.44.

Acadia Healthcare Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.